- Lipocine Announces Financial Results For The Year Ended December 31, 2020
- Lipocine To Present At M Vest / Maxim Conference And At The Lytham Partners Conference
- Lipocine Announces Publication in Journal of Endocrinological Investigation Highlighting the Potential of LPCN 1144 in the Treatment of NASH and Hepatic Fibrosis
- Lipocine Announces Presentations on TLANDO™ at ENDO 2021 Conference
- Lipocine to Present at Two Upcoming Investor Conferences
- Lipocine Closes Underwritten Public Offering Of Common Stock
- Lipocine Prices $25 Million Underwritten Public Offering Of Common Stock
- Lipocine Announces Launch Of Public Offering Of Common Stock
Lipocine Inc (2VT:DEU) closed at 1.15, 180.98% above the 52 week low of 0.41 set on Apr 20, 2020.
0.41Apr 20 20202.16Jan 21 2021
Markit short selling activity
|Market cap||122.72m USD|
|EPS (TTM)||-0.4017 |
Data delayed at least 15 minutes, as of Apr 20 2021 17:42 BST.